Novartis’ Sandoz yanks one lot of deep vein thrombosis injectable after exposure to heat during shipping

A steamy shipping glitch has forced Novartis’ generics unit to yank a batch of deep vein thrombosis meds from U.S. shelves.Â
Sandoz is recalling one lot of enoxaparin sodium injection single-dose syringes after part of the batch was exposed to high temperatures during shipping. The balmy…
Source: www.fiercepharma.com – Read more